BR0307048A - Composição farmacêutica orodispersìvel de perindoprila - Google Patents

Composição farmacêutica orodispersìvel de perindoprila

Info

Publication number
BR0307048A
BR0307048A BR0307048-4A BR0307048A BR0307048A BR 0307048 A BR0307048 A BR 0307048A BR 0307048 A BR0307048 A BR 0307048A BR 0307048 A BR0307048 A BR 0307048A
Authority
BR
Brazil
Prior art keywords
perindopril
pharmaceutical composition
orodispersible pharmaceutical
orodispersible
perindoprila
Prior art date
Application number
BR0307048-4A
Other languages
English (en)
Other versions
BRPI0307048B1 (pt
Inventor
Patrick Wuthrich
Herve Rolland
Marc Julien
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of BR0307048A publication Critical patent/BR0307048A/pt
Publication of BRPI0307048B1 publication Critical patent/BRPI0307048B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA ORODISPERSìVEL DE PERINDOPRILA". A presente invenção refere-se a uma composição farmacêutica sólida orodispersível de perindoprila, caracterizada pelo fato de que compreende perindoprila, ou um sal farmaceuticamente aceitável de perindoprila, e grânulos que consistem de lactose e amido co-secos.
BRPI0307048-4A 2002-01-23 2003-01-22 Composição farmacêutica sólida orodispersível de perindoprila, comprimido e uso de grânulos que consistem em lactose e amido co-secos BRPI0307048B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0200790A FR2834893B1 (fr) 2002-01-23 2002-01-23 Composition pharmaceutique orodispersible de perindopril
PCT/FR2003/000200 WO2003061691A1 (fr) 2002-01-23 2003-01-22 Composition pharmaceutique orodispersible de perindopril

Publications (2)

Publication Number Publication Date
BR0307048A true BR0307048A (pt) 2004-10-26
BRPI0307048B1 BRPI0307048B1 (pt) 2015-06-30

Family

ID=27589554

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0307048-4A BRPI0307048B1 (pt) 2002-01-23 2003-01-22 Composição farmacêutica sólida orodispersível de perindoprila, comprimido e uso de grânulos que consistem em lactose e amido co-secos

Country Status (27)

Country Link
US (3) US20050106237A1 (pt)
EP (1) EP1467750B1 (pt)
JP (1) JP4090997B2 (pt)
KR (1) KR100588224B1 (pt)
CN (1) CN1658898B (pt)
AR (1) AR038305A1 (pt)
AT (1) ATE332690T1 (pt)
AU (1) AU2003215708B2 (pt)
BR (1) BRPI0307048B1 (pt)
CA (1) CA2473205C (pt)
CY (1) CY1105655T1 (pt)
DE (1) DE60306747T2 (pt)
DK (1) DK1467750T3 (pt)
EA (1) EA007181B1 (pt)
ES (1) ES2268372T3 (pt)
FR (1) FR2834893B1 (pt)
GE (1) GEP20063821B (pt)
HK (1) HK1076743A1 (pt)
MA (1) MA27099A1 (pt)
MX (1) MXPA04007195A (pt)
NO (1) NO333723B1 (pt)
NZ (1) NZ533821A (pt)
PL (1) PL205473B1 (pt)
PT (1) PT1467750E (pt)
UA (1) UA78279C2 (pt)
WO (1) WO2003061691A1 (pt)
ZA (1) ZA200405009B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005067887A2 (en) * 2004-03-24 2005-07-28 Actavis Group Formulations of ramipril
DE102004019845A1 (de) * 2004-03-29 2005-10-20 Krka Tovarna Zdravil D D Verfahren zur Herstellung einer festen pharmazeutischen Zusammensetzung
SK50252005A3 (sk) * 2005-03-22 2006-10-05 Vúlm, A.S. Farmaceutický prípravok obsahujúci perindopril erbumín, spôsob jeho prípravy a stabilizácie
GB0518129D0 (en) * 2005-09-06 2005-10-12 Arrow Int Ltd Ramipril formulation
US20070098782A1 (en) * 2005-10-28 2007-05-03 Selamine Limited Ramipril Formulation
GB2431579A (en) * 2005-10-28 2007-05-02 Arrow Int Ltd Ramipril formulations
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
SI2886108T2 (sl) 2013-12-23 2023-02-28 Dr. Falk Pharma Gmbh Optimizirana farmacevtska formulacija za zdravljenje vnetnih sprememb požiralnika
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3506276C1 (de) * 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direkttablettiermittel
AU699715B2 (en) * 1994-01-31 1998-12-10 Astellas Pharma Inc. Intrabuccally dissolving compressed moldings and production process thereof
JP2002505269A (ja) * 1998-03-06 2002-02-19 エウランド インターナショナル ソシエタ ペル アチオニ 急速崩壊錠剤
WO2000078292A1 (fr) * 1999-06-18 2000-12-28 Takeda Chemical Industries, Ltd. Preparations solides a desintegration rapide
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
ES2292414T3 (es) * 2000-07-27 2008-03-16 Roquette Freres Granulos a base de almidon y de lactosa.
US6651768B2 (en) * 2000-11-06 2003-11-25 Bombardier Inc. Snowmobile engine mount
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible

Also Published As

Publication number Publication date
UA78279C2 (en) 2007-03-15
CA2473205A1 (fr) 2003-07-31
EP1467750B1 (fr) 2006-07-12
AU2003215708B9 (en) 2003-09-02
AU2003215708B2 (en) 2007-07-19
FR2834893A1 (fr) 2003-07-25
US20120076856A1 (en) 2012-03-29
FR2834893B1 (fr) 2004-02-27
CY1105655T1 (el) 2010-12-22
DE60306747T2 (de) 2007-08-02
WO2003061691A1 (fr) 2003-07-31
JP2005523256A (ja) 2005-08-04
PL370162A1 (en) 2005-05-16
CN1658898A (zh) 2005-08-24
GEP20063821B (en) 2006-05-10
ATE332690T1 (de) 2006-08-15
ZA200405009B (en) 2005-08-31
KR100588224B1 (ko) 2006-06-12
NO333723B1 (no) 2013-09-02
AR038305A1 (es) 2005-01-12
BRPI0307048B1 (pt) 2015-06-30
MA27099A1 (fr) 2004-12-20
NO20043473L (no) 2004-08-20
ES2268372T3 (es) 2007-03-16
PL205473B1 (pl) 2010-04-30
JP4090997B2 (ja) 2008-05-28
DK1467750T3 (da) 2006-11-13
KR20040078130A (ko) 2004-09-08
US20050106237A1 (en) 2005-05-19
CN1658898B (zh) 2012-10-03
EA007181B1 (ru) 2006-08-25
EA200400884A1 (ru) 2004-12-30
NZ533821A (en) 2005-08-26
HK1076743A1 (en) 2006-01-27
AU2003215708B8 (en) 2003-09-02
MXPA04007195A (es) 2004-10-29
US20100267799A1 (en) 2010-10-21
DE60306747D1 (de) 2006-08-24
EP1467750A1 (fr) 2004-10-20
CA2473205C (fr) 2010-05-18
PT1467750E (pt) 2006-11-30

Similar Documents

Publication Publication Date Title
BR0307072A (pt) Composição farmacêutica orodispersìvel de agomelatina
YU92501A (sh) Levodop/karbidop/entakapon farmaceutski preparat
EA200800064A1 (ru) Композиция в виде гранул с модифицированным и немедленным высвобождением мемантина
TR200401793T4 (tr) Perindopril tuzu ve bunu içeren farmasötik bileşimler.
BR0317392A (pt) Formulação não-higroscópica incluindo uma droga higroscópica
HK1070305A1 (en) Pharmaceutical composition comprising gabapentin or an analogue thereof and an sg(a)-aminoamide and its analgesic use
BR0207930A (pt) Composições farmacêuticas lìquidas com sabor mascarado
HUP0004433A2 (hu) Granulált édesítőszer
BR0307048A (pt) Composição farmacêutica orodispersìvel de perindoprila
CY1108854T1 (el) Οροδιασπειρoμενη φαρμακευτικη συνθεση ιβαβραδινης
EA200401227A1 (ru) Система доставки лекарства с контролируемым высвобождением, включающая правастатин
BR0208161A (pt) Forma farmacêutica sólida orodispersìvel
BR0314129A (pt) Formulações de liberação modificadas de oxcarbazepina e derivados destas
BR0213449A (pt) Comprimido mastigável contendo lisina
ITMI20022394A1 (it) Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
BR0306869A (pt) Composição farmacêutica orodispersìvel de piribedila
ATE387100T1 (de) Calciumsalz enthaltender kaugummi
BRPI0412706A (pt) composição farmacêutica orodispersìvel de um composto antitrombótico
ATE387857T1 (de) Calcium enthaltende süssigkeit
DK1497250T3 (da) Hyperforinderivater, anvendelse heraf og sammensætninger indeholdende disse
BR0212254A (pt) Composição farmaceutica
ITMI20030827A1 (it) Composizione farmaceutica contenente l'associazione levodopa/carbidopa.
EP1498145A4 (en) LURE FOR THE TREATMENT AND / OR PREVENTION OF ALLERGIC DISEASE ASSOCIATED WITH CYTOKINE TH2, MUTANT PROTEIN GATA3 AND MEDICINAL COMPOSITIONS CONTAINING THE SAME
ES2127133A1 (es) Utilizacion de derivados 2,5-dihidroxibencenosulfonicos para la fabricacion de medicamentos destinados al tratamiento y a la prevencion de la enfermedad de alzheimer.
SI1560575T1 (sl) 3,5,3'-trijodotironin-sulfat kot tiromimeticna ucinkovina in njegove farmacevtske oblike

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 30/06/2015, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 17A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2550 DE 19-11-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.